Research Paper Volume 15, Issue 10 pp 4159—4181
Characteristic of molecular subtypes based on PANoptosis-related genes and experimental verification of hepatocellular carcinoma
Figure 9. Genetic mutation characteristic and immunotherapy response of risk subgroups. Evaluation of somatic mutation landscape of HCC samples in (A) low- and (B) high-risk groups. (C–F) Immunotherapy response exploration of risk subgroups. (G) Difference analysis of immune checkpoints in the risk subgroups.